Labels
Breast Cancers
(147)
Genitourinary Cancers
(73)
Lung Cancers
(73)
Gastrointestinal Cancers
(67)
Gynecological Cancers
(56)
Head and Neck Cancers
(50)
Cutaneous Cancers
(21)
Central Nervous System Cancers
(11)
Monday, 10 March 2014
Investigational drug may increase survival for some patients with advanced melanoma
An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. All patients had experienced disease progression despite prior systemic therapies, and most had received two or more prior treatments. Read more here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment